Bray F,Ferlay J,Soerjomataram I,Siegel RL,Torre LA,Jemal A .2018 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68 : 394-424.
Mahmood S,Faraz R,Yousaf A,Quader A,Asif H,Atif A .2016 .Annual cancer registry report-2016, of the Shaukat Khanum Memorial Cancer Hospital. , : .
Mori K,D'Andrea D,Enikeev DV,Egawa S,Shariat SF .2020 .En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature. Curr Opin Urol, 30 : 41-7.
Lyon .2022 .WHO classification of tumours: urinary and male genital tumours. ed. 5, 8 : .
Dobruch J,Oszczudłowski M. .2021 .Bladder cancer: current challenges and future directions. Medicina, 57 : 749-54.
Fujii Y. .2018 .Prediction models for progression of non‐muscleinvasive bladder cancer: a review. Int J Urol, 25 : 212-8.
Stec R,Cierniak S,Lubas A,Brzóskowska U,Syryło T,Zieliński H .2020 .Intensity of nuclear staining for Ki-67, p53 and surviving as a new prognostic factor in nonmuscle invasive bladder cancer. Pathol Oncol Res, 26 : 1211-9.
Thakur B,Kishore S,Dutta K,Kaushik S,Bhardwaj A .2017 .Role of p53 and Ki-67 immunomarkers in carcinoma of urinary bladder. Ind J Pathol Microbiol, 60 : 505-9.
Rodriguez Pena MD,Chaux A,Eich ML,Tregnago AC,Taheri D,Borhan W .2019 .Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder. Virchows Arch, 475 : 349-56.
Hodgson A,Xu B,Downes MR .2017 .p53 immunohistochemistry in high‐grade urothelial carcinoma of the bladder is prognostically significant. Histopathology, 71 : 296-304.
Ko K,Jeong CW,Kwak C,Kim HH,Ku JH .2017 .Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis. Oncotarget, 8 : 100614.
Hasan A,Mohammed Y,Basiony M,Hanbazazh M,Samman A,Abdelaleem MF .2023 .Clinico-pathological features and immunohistochemical comparison of p16, p53, and Ki-67 expression in muscle-invasive and nonmuscle-invasive conventional urothelial bladder carcinoma. Clin Pract, 13 : 806-19.
Vetterlein MW,Roschinski J,Gild P,Marks P,Soave A .2017 .Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder. Transl Androl Urol, 6 : 1018-22.
Ahmad Z,Idress R,Fatima S,Uddin N,Ahmed A,Minhas K .2016 .Commonest cancers in Pakistan-findings and histopathological perspective from a premier surgical pathology center in Pakistan. Asian Pac J Cancer Prev, 17 : 1061.
Jones TD .2021 .Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups. Eur Urol, 79 : 489-91.
Altaf J,Mahesar MA,Jatoi T. .2017 .Clinicopathological features of bladder tumors in a single institution in Hyderabad, Sindh, Pakistan. Int J Clin Case Stud, 1 : 22-9.
Qamar S,Inam QA,Ashraf S,Khan MS,Khokhar MA,Awan N. .2017 .Prognostic value of p53 expression intensity in urothelial cancers. J Coll Physicians Surg Pak, 27 : 232-6.
Brossart DF,Laird VC,Armstrong TW .2018 .Interpreting Kendall's Tau and Tau-U for single-case experimental designs. Cogent Psychol, 5 : 1518687.
Khurshid IK,Ahmad M,Javed S,Aneeqa S,Gardezi A,Waqar M. p53,Pakistan. JIIMC M. p53 .2021 .and ki-67 expression in papillary urothelial carcinomas of urinary bladder, an experience. , 16 : 74-8.